Multiparameter Flow Cytometry Analysis of Peripheral Blood T, NK and Dendritic Cells From High-Risk Smoldering Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone

被引：0

作者：

Paiva, Bruno ^{[1
]}

Lopez-Corral, Lucia ^{[1
]}

Vidriales, Maria-Belen ^{[1
]}

Sanchez Abarca, Luis Ignacio ^{[1
]}

Hernandez, Miguel T. ^{[2
]}

Bargay, Joan ^{[3
]}

De La Rubia, Javier ^{[4
]}

Giraldo, Pilar ^{[5
]}

Teruel, Ana-Isabel ^{[6
]}

Rosinol, Laura ^{[7
]}

Oriol, Albert ^{[8
]}

Hernandez, Jose ^{[9
]}

de Arriba, Felipe ^{[10
]}

Esteves, Graca ^{[11
]}

Perez Simon, Jose Antonio ^{[1
]}

Mateos, Maria-Victoria ^{[1
]}

San Miguel, Jesus F. ^{[12
]}

机构：

[1] Hosp Univ Salamanca, Salamanca, Spain

[2] Hosp Univ Canarias, Serv Hematol Clin, Tenerife, Spain

[3] CETLAM Cooperat Grp, Palma de Mallorca, Spain

[4] Hosp La Fe, E-46009 Valencia, Spain

[5] Hosp Miguel Servet, Zaragoza, Spain

[6] Hosp Clin Univ Valencia, Valencia, Spain

[7] Hosp Clin Barcelona, Barcelona, Spain

[8] CETLAM Cooperat Grp, Badalona, Spain

[9] Hosp Gen Segovia, Segovia, Spain

[10] Hosp Morales Messeguer, Murcia, Spain

[11] Hosp Santa Maria, Lisbon, Portugal

[12] Hosp Clin Univ, Salamanca, Spain

来源：

BLOOD | 2010年 / 116卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：794 / 795

页数：2

共 50 条

[21] COLLECTION AND TRANSPLANTATION OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE
Grubovic, R. M.
Alavi, A.
Schiller, G. J.
BONE MARROW TRANSPLANTATION, 2014, 49 : S49 - S49
[22] Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca Study
Mateos, Maria-Victoria
Rodriguez Otero, Paula
Koh, Youngil
Martinez-Lopez, Joaquin
Parmar, Gurdeep
Prince, H. Miles
Quach, Hang
Ribas, Paz
Hermansen, Emil
Hungria, Vania T. M.
Besisik, Sevgi Kalayoglu
Kim, Jin Seok
Leleu, Xavier
Peceliunas, Valdas
Schjesvold, Fredrik
Sevindik, Omur G.
Lavrova, Tatiana
Dubin, Franck
Devisme, Christine
Lepine, Lucie
Mace, Sandrine
Morisse, Mony
Ghobrial, Irene
BLOOD, 2022, 140 : 7317 - 7319
[23] Clinical and Correlative Pilot Study Of Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Extended Dosing (CRd - R) In High Risk Smoldering Multiple Myeloma Patients
Landgren, Ola
Mailankody, Sham
Kwok, Mary
Manasanch, Elisabet E.
Bhutani, Manisha
Tageja, Nishant
Kazandjian, Dickran
Zingone, Adriana
Costello, Rene
Burton, Debra
Zhang, Yong
Wu, Peter
Carter, George
Mulquin, Marcia
Zuchlinski, Diamond
Maric, Irina
Calvo, Katherine R.
Braylan, Raul C.
Yuan, Constance
Stetler-Stevenson, Maryalice
Arthur, Diane C.
Lindenberg, Liza
Kurdziel, Karen
Choyke, Peter
Steinberg, Seth M.
Roschewski, Mark
Korde, Neha
BLOOD, 2013, 122 (21)
[24] T-cell receptor repertoire analysis by next-generation sequencing peripheral blood mononuclear cells from multiple myeloma or smoldering multiple myeloma patients
Zhang, Yong
Petrovskaya, Svetlana
Scott, Emma C.
Santana-Quintero, Luis
Ghazanchyan, Tigran
Rosenburg, Amy
Rao, V. Ashutosh
Blumenthal, Gideon M.
Theoret, Marc
Pazdur, Richard
Beaver, Julia A.
Kazandjian, Dickran
CANCER RESEARCH, 2019, 79 (13)
[25] Low-Dose Dexamethasone Does Not Abrogate the Immunomodulatory Effects of Lenalidomide and Both Reactivate the Impaired Immune System of High-Risk Smoldering Multiple Myeloma Patients
Paiva, Bruno
Mateos, Maria-Victoria
Ignacio Sanchez-Abarca, Luis
Belen Vidriales, Maria
Lopez-Corral, Lucia
Corchete, Luis A.
Hernandez, Miguel T.
Bargay, Joan
De Arriba, Felipe
De la Rubia, Javier
Isabel Teruel, Ana
Giraldo, Pilar
Rosinol, Laura
Prosper, Felipe
Oriol, Albert
Mariano Hernandez, Jose
Esteves, Graca
da Costa, Fernando Leal
Jose Lahuerta, Juan
Blade, Joan
Perez-Simon, Jose A.
San Miguel, Jesus
BLOOD, 2015, 126 (23)
[26] Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone
Avet-Loiseau, H.
Soulier, J.
Fermand, J-P
Yakoub-Agha, I.
Attal, M.
Hulin, C.
Garderet, L.
Belhadj, K.
Dorvaux, V.
Minvielle, S.
Moreau, P.
LEUKEMIA, 2010, 24 (03) : 623 - 628
[27] Prognostic role of the ratio of natural killer cells to regulatory T cells in patients with multiple myeloma treated with lenalidomide and dexamethasone
Kim, Seung Yeon
Park, Sung-Soo
Lim, Ji-Young
Lee, Jung Yeon
Yoon, Jae-Ho
Lee, Sung-Eun
Eom, Ki-Seong
Kim, Hee-Je
Min, Chang-Ki
EXPERIMENTAL HEMATOLOGY, 2022, 110 : 60 - 68
[28] Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression
W I Gonsalves
S V Rajkumar
A Dispenzieri
D Dingli
M M Timm
W G Morice
M Q Lacy
F K Buadi
R S Go
N Leung
P Kapoor
S R Hayman
J A Lust
S J Russell
S R Zeldenrust
L Hwa
T V Kourelis
R A Kyle
M A Gertz
S K Kumar
Leukemia, 2017, 31 : 130 - 135
[29] Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression
Gonsalves, W. I.
Rajkumar, S. V.
Dispenzieri, A.
Dingli, D.
Timm, M. M.
Morice, W. G.
Lacy, M. Q.
Buadi, F. K.
Go, R. S.
Leung, N.
Kapoor, P.
Hayman, S. R.
Lust, J. A.
Russell, S. J.
Zeldenrust, S. R.
Hwa, L.
Kourelis, T. V.
Kyle, R. A.
Gertz, M. A.
Kumar, S. K.
LEUKEMIA, 2017, 31 (01) : 130 - 135
[30] New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells
Perez-Persona, Ernesto
Vidriales, Maria-Belen
Mateo, Gema
Garcia-Sanz, Ramon
Mateos, Maria-Victoria
de Coca, Alfonso Garcia
Galende, Josefina
Martin-Nunez, Guillermo
Alonso, Jose M.
de las Heras, Natalia
Hernandez, Jose M.
Martin, Alejandro
Lopez-Berges, Consuelo
Orfao, Alberto
San Miguel, Jesus F.
BLOOD, 2007, 110 (07) : 2586 - 2592

← 1 2 3 4 5 →